Accessibility Menu

Bioxyne(ASX) BLS

Market CapA$190.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-39%
5 Year+196%
1 Year+80%
1 Month-12%
A$0.83
+2.47%
+0.02Today
Bioxyne last closing stock price
MetricPriceDate
Last closeAUD 0.832026-08-03
Bioxyne stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.84%AUD 0.822026-07-27
1 month-11.7%AUD 0.942026-07-03
3 month+38.33%AUD 0.602026-05-05
Year to date+97.62%AUD 0.422025-12-31
1 year+80.43%AUD 0.462025-08-01
3 year+361.11%AUD 0.182023-08-03
5 year+196.43%AUD 0.282021-07-30
Since inception-39.1%AUD 1.332012-04-10

Bioxyne Financials at a Glance

Market Cap

A$190.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

A$0.04

P/E Ratio

20.44

Dividend

A$0.00

Beta (Volatility)

-0.13 (Low)

Price

A$0.83

Volume

0

Open

A$0.83

Previous Close

A$0.83

Daily Range

A$0.83 - A$0.85

52-Week Range

A$0.33 - A$1.10

Estimated Earnings Date

N/A

BLS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioxyne

Bioxyne Ltd. engages in the research, development, market and distribution of health products. It operates through the Wholesale Sales, and Direct Sales segments. The Wholesale Sales segment covers operation in United States of America (USA), and Asia. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Sam Watson

Website

www.bioxyne.com

Headquarters

Sydney, NSW 2000, AU

BLS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

65.19%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.89%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

A$190.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

229.10M

Volume

0

Avg. Volume

349.06K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bioxyne Performance Analysis

Bioxyne annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 463,636N/A
20232023-06-30AUD 5,154,4151011.7%
20242024-06-30AUD 9,325,02080.9%
20252025-06-30AUD 28,429,544204.9%
Bioxyne annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.01N/A
20232023-06-30AUD -0.01114.9%
20242024-06-30AUD -0.07377.8%
20252025-06-30AUD 0.02N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

A$190.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,599.89+0.01%
^DJIDJI
$53,111.44+0.01%
^IXICNASDAQ
$25,916.74+0.02%
BTCBitcoin
$63,822.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About BLS

What is the current price of Bioxyne?

Bioxyne is trading at A$0.83 per share.

What is the 52-week range for Bioxyne?

Over the past 52 weeks, Bioxyne has traded between A$0.33 and A$1.10.

How much debt does Bioxyne have?

As of the most recent reporting period, Bioxyne reported total debt of A$1.53M.

How much cash does Bioxyne have on hand?

Bioxyne reported A$7.67M in cash and cash equivalents in its most recent financial results.

What is Bioxyne’s dividend yield?

Bioxyne does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services